Qualium Investissement has structured its first continuation fund to bolster its partnership with Proengin, enhancing the latter's global growth in NRBC threat detection solutions.

Target Information

Qualium Investissement, a prominent French private equity firm, has successfully structured its first continuation fund to enhance its collaboration with Proengin, a leading provider of sovereign Nuclear, Radiological, Biological, and Chemical (NRBC) threat detection solutions. This continuation fund was established following a competitive process that garnered significant interest from various investors and is notably led by Eurazeo, acting as the Lead Investor. The deal also includes participation from several secondary investors and existing partners of Qualium Fund II.

This transaction not only allows Qualium Investissement to retain Proengin, the recognized champion in NRBC threat detection, within its investment portfolio but also provides Proengin with crucial new capital aimed at accelerating its international growth. The management team at Proengin, spearheaded by Chairman Jean-François Brun, is making substantial reinvestments in this deal, which will channel funds into strategies for further global expansion.

Industry Overview

The market for Nuclear, Radiological, Biological, and Chemical (NRBC) threat detection in France is characterized by a growing demand for advanced security technologies. As global tensions rise and threats evolve, both governmental and priv